These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30328514)

  • 1. How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
    Benes LB; Brandt DJ; Brandt EJ; Davidson MH
    Curr Cardiol Rep; 2018 Oct; 20(12):138. PubMed ID: 30328514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.
    Khera AV; Rader DJ
    Trends Cardiovasc Med; 2009 Aug; 19(6):195-201. PubMed ID: 20211435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GENOMICS AND SYSTEMS BIOLOGY APPROACHES IN THE STUDY OF LIPID DISORDERS.
    Rodríguez A; Pajukanta P
    Rev Invest Clin; 2018; 70(5):217-223. PubMed ID: 30307448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.
    Benn M; Nordestgaard BG
    Cardiovasc Res; 2018 Jul; 114(9):1192-1208. PubMed ID: 29471399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention.
    Orho-Melander M
    J Intern Med; 2015 Nov; 278(5):433-46. PubMed ID: 26477595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From lipid locus to drug target through human genomics.
    van der Laan SW; Harshfield EL; Hemerich D; Stacey D; Wood AM; Asselbergs FW
    Cardiovasc Res; 2018 Jul; 114(9):1258-1270. PubMed ID: 29800275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: A step toward personalized nutrition.
    Mehramiz M; Ghasemi F; Esmaily H; Tayefi M; Hassanian SM; Sadeghzade M; Sadabadi F; Moohebati M; Azarpazhooh MR; Parizadeh SMR; Heidari-Bakavoli A; Safarian M; Nematy M; Ebrahimi M; Ryzhikov M; Ferns GA; Ghayour-Mobarhan M; Avan A
    Clin Nutr; 2018 Feb; 37(1):254-261. PubMed ID: 28065479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.
    Hoffmann MM
    Curr Cardiol Rep; 2018 May; 20(7):56. PubMed ID: 29802474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.
    Ouzounian M; Lee DS; Gramolini AO; Emili A; Fukuoka M; Liu PP
    Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):28A-33A. PubMed ID: 17668085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
    Joyner MJ
    Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics: Implications for Prevention and Management of Coronary Artery Disease.
    Assimes TL; Roberts R
    J Am Coll Cardiol; 2016 Dec; 68(25):2797-2818. PubMed ID: 28007143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Role of Precision Medicine in Cardiovascular Disease.
    Leopold JA; Loscalzo J
    Circ Res; 2018 Apr; 122(9):1302-1315. PubMed ID: 29700074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Genetics and Genomics: Closing the Phenotype Gap in Precision Medicine.
    MacRae CA; Vasan RS
    Circulation; 2016 Jun; 133(25):2634-9. PubMed ID: 27324359
    [No Abstract]   [Full Text] [Related]  

  • 15. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.
    Arnett DK; Baird AE; Barkley RA; Basson CT; Boerwinkle E; Ganesh SK; Herrington DM; Hong Y; Jaquish C; McDermott DA; O'Donnell CJ; ; ;
    Circulation; 2007 Jun; 115(22):2878-901. PubMed ID: 17515457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik M; Dlouha D; Todorovova V; Stefler D; Hubacek JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Strategy for Genomic Research on Common Cardiovascular Diseases Aiming at the Realization of Precision Medicine: Personal Insights and Perspectives.
    Morita H; Komuro I
    Circ Res; 2016 Sep; 119(8):900-3. PubMed ID: 27688306
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era.
    O'Donnell CJ; Nabel EG
    Circ Cardiovasc Genet; 2008 Oct; 1(1):51-7. PubMed ID: 20031542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics of Cardiometabolic Disorders in Sub-Saharan Africa.
    Adebamowo SN; Tekola-Ayele F; Adeyemo AA; Rotimi CN
    Public Health Genomics; 2017; 20(1):9-26. PubMed ID: 28482349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for treating lipids for prevention: risk stratification models with and without imaging.
    Okwuosa TM; Mallikethi-Reddy S; Jones DM
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):295-307. PubMed ID: 24840260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.